Why ASX healthcare shares are a no-brainer for the 2020s

Here's why I think ASX healthcare shares like CSL Limited (ASX: CSL) are a no-brainer for 2020 investments.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I would describe ASX healthcare shares as a somewhat 'under-the-radar' sector of the share market. Sure, market-darling CSL Limited (ASX: CSL) has managed to sneak up to be one of the most popular ASX shares to hold in a modern portfolio.

But out of the ASX 50 (that's the largest 50 Aussie public companies) – only 4 are classified as belonging to the healthcare industry.

They are CSL, Ramsay Health Care Limited (ASX: RHC), Sonic Healthcare Limited (ASX: SHL) and Cochlear Limited (ASX: COH).

If you were splitting hairs, you could also throw in Medibank Private Ltd (ASX: MPL), although it's technically a Financial.

But I think healthcare is one of the best places to be investing as we begin the new decade. In my view, the under-representation of healthcare in the ASX 50 just means there's plenty of room for growth!

Why?

Well, I have 2 rock-solid (in my opinion, anyway) reasons.

a woman

1. Ageing demographics

It's no secret that our population is ageing. According to reporting in the Sydney Morning Herald, it's estimated that by the year 2056, there is expected to be just 2 workers for every 1 retiree – down from today's ratio of 4-to-1.

That's a scary statistic, but it's also one that I think indicates a lot of potential in the healthcare sector for investing today.

2. Government support

As our population ages, there is going to inevitably be more pressure on government services to provide the same level of care from fewer taxes being proportionally paid by less workers. As a result, I expect governments to increasingly rely on the private sector to fill this gap.

This might come through the use of higher tax incentives like the private health insurance rebate and Medicare levy, or grants to private health providers to shoulder some of this burden.

Whichever way the cookie crumbles, I think this sector will stand to benefit as we stare down this barrel.

Yes, I think the government will be buying more vaccines from CSL as time goes on.

Yes, I think Ramsay Health Care (and its extensive network of private hospitals) will benefit in more than one way from government policy in the future.

And yes, I think Medibank and other private insurers will continue to be encouraged by the state to take some of the pressure off Medicare.

Foolish takeaway

All in all, healthcare is a sector that I believe is a no-brainer to be investing in this decade and beyond, for the reasons outlined above. By looking at the demographic trends that are hitting our population, it's really not too hard to imagine the benefits that are going to flow into the healthcare sector as a whole. It's a pie I certainly want a slice of!

Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd., Ramsay Health Care Limited, and Sonic Healthcare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Bell Potter says this ASX biotech could nearly double in value

The US market is starting to open up for this company.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Integral Diagnostics posts profit and dividend growth in FY26

Integral Diagnostics FY26 earnings show revenue and profit growth, higher dividend, and a positive outlook for investors.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

This ASX small-cap healthcare stock is tipped to double in value

This company has a good base to build on.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Neuren share price in focus after DAYBU wins EU approval for Rett syndrome

Neuren shares are on watch after DAYBU (trofinetide) won European approval, unlocking commercial milestones and revenue opportunities.

Read more »

Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital
Earnings Results

Nanosonics posts FY26 revenue growth and prepares to launch CORIS

Nanosonics FY26 earnings show steady revenue growth and set the stage for the CORIS commercial launch.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Special dividend: Is now the time to buy NIB shares for income?

NIB shares now offer a yield well over 4%.

Read more »

Three healthcare workers standing together and smiling.
Healthcare Shares

Regis Healthcare reports higher FY26 profits and dividend

Regis Healthcare delivered higher revenue, profit and dividends in FY26, with occupancy and acquisitions driving strong results.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Healthcare Shares

Could CSL shares really hit $200? Experts reveal their 12-month targets

Brokers warn CSL’s spectacular rebound doesn’t guarantee further gains.

Read more »